Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05122247 · ClinicalTrials.gov registry record
Machine Learning to Predict Acute Care During Cancer Therapy
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 12,000
- Enrollment target
NCT05122247: Completed study, sponsored by Duke University.
NCT05122247 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 12,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05122247 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 12,000 participants
- Enrollment target
Study Summary
The objective of this study is to apply a validated machine-learning based model (SHIELD-RT, NCT04277650) to a cohort of patients undergoing systemic therapy as outpatient cancer treatment to generate an automatic system for the prediction of unplanned hospital admission rates and emergency department encounters.
Interventions
- OTHER Machine learning algorithm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,000 participants |
| Start Date | 2022-01-03 |
| Est. Completion | 2023-09-19 |
What the finished NCT05122247 record still lists
NCT05122247 is an observational study that tracks outcomes without assigning an intervention. Its 12,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Machine learning algorithm is the first listed.
NCT05122247 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05122247 about?
NCT05122247 is a clinical study titled "Machine Learning to Predict Acute Care During Cancer Therapy". The objective of this study is to apply a validated machine-learning based model (SHIELD-RT, NCT04277650) to a cohort of patients undergoing systemic therapy as outpatient cancer treatment to generate an automatic system for the prediction of unplanned hospital admission rates and emergency departme...
What is the current status of trial NCT05122247?
This trial is currently completed. The enrollment target is 12,000 participants. The study started on 2022-01-03. Estimated completion is 2023-09-19.
What interventions are being tested in trial NCT05122247?
The interventions under investigation include: Machine learning algorithm (OTHER).
Who is sponsoring clinical trial NCT05122247?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01772771 · 12,000 participants
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
- NCT04937868 · 12,000 participants
Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
- NCT06059963 · 12,000 participants
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
- NCT06273618 · 12,000 participants · NA
iLookOut Micro-learning to Improve Knowledge Retention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI